218 related articles for article (PubMed ID: 10506125)
1. Role of cytochrome c as a stimulator of alpha-synuclein aggregation in Lewy body disease.
Hashimoto M; Takeda A; Hsu LJ; Takenouchi T; Masliah E
J Biol Chem; 1999 Oct; 274(41):28849-52. PubMed ID: 10506125
[TBL] [Abstract][Full Text] [Related]
2. The ceruloplasmin and hydrogen peroxide system induces alpha-synuclein aggregation in vitro.
Kim KS; Choi SY; Kwon HY; Won MH; Kang TC; Kang JH
Biochimie; 2002 Jul; 84(7):625-31. PubMed ID: 12453634
[TBL] [Abstract][Full Text] [Related]
3. Oxidative stress induces amyloid-like aggregate formation of NACP/alpha-synuclein in vitro.
Hashimoto M; Hsu LJ; Xia Y; Takeda A; Sisk A; Sundsmo M; Masliah E
Neuroreport; 1999 Mar; 10(4):717-21. PubMed ID: 10208537
[TBL] [Abstract][Full Text] [Related]
4. The Role of alpha-synuclein assembly and metabolism in the pathogenesis of Lewy body disease.
Hashimoto M; Kawahara K; Bar-On P; Rockenstein E; Crews L; Masliah E
J Mol Neurosci; 2004; 24(3):343-52. PubMed ID: 15655259
[TBL] [Abstract][Full Text] [Related]
5. Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions.
Giasson BI; Duda JE; Murray IV; Chen Q; Souza JM; Hurtig HI; Ischiropoulos H; Trojanowski JQ; Lee VM
Science; 2000 Nov; 290(5493):985-9. PubMed ID: 11062131
[TBL] [Abstract][Full Text] [Related]
6. Formation of hydrogen peroxide and hydroxyl radicals from A(beta) and alpha-synuclein as a possible mechanism of cell death in Alzheimer's disease and Parkinson's disease.
Tabner BJ; Turnbull S; El-Agnaf OM; Allsop D
Free Radic Biol Med; 2002 Jun; 32(11):1076-83. PubMed ID: 12031892
[TBL] [Abstract][Full Text] [Related]
7. alpha-Synuclein filaments bind the transcriptional regulator HMGB-1.
Lindersson EK; Højrup P; Gai WP; Locker D; Martin D; Jensen PH
Neuroreport; 2004 Dec; 15(18):2735-9. PubMed ID: 15597044
[TBL] [Abstract][Full Text] [Related]
8. Cellular co-localization of phosphorylated tau- and NACP/alpha-synuclein-epitopes in lewy bodies in sporadic Parkinson's disease and in dementia with Lewy bodies.
Arima K; Hirai S; Sunohara N; Aoto K; Izumiyama Y; Uéda K; Ikeda K; Kawai M
Brain Res; 1999 Oct; 843(1-2):53-61. PubMed ID: 10528110
[TBL] [Abstract][Full Text] [Related]
9. Aggregation of alpha-synuclein induced by the Cu,Zn-superoxide dismutase and hydrogen peroxide system.
Kim KS; Choi SY; Kwon HY; Won MH; Kang TC; Kang JH
Free Radic Biol Med; 2002 Mar; 32(6):544-50. PubMed ID: 11958955
[TBL] [Abstract][Full Text] [Related]
10. Metal-catalyzed oxidation of alpha-synuclein in the presence of Copper(II) and hydrogen peroxide.
Paik SR; Shin HJ; Lee JH
Arch Biochem Biophys; 2000 Jun; 378(2):269-77. PubMed ID: 10860544
[TBL] [Abstract][Full Text] [Related]
11. alpha-Synuclein implicated in Parkinson's disease catalyses the formation of hydrogen peroxide in vitro.
Turnbull S; Tabner BJ; El-Agnaf OM; Moore S; Davies Y; Allsop D
Free Radic Biol Med; 2001 May; 30(10):1163-70. PubMed ID: 11369507
[TBL] [Abstract][Full Text] [Related]
12. Aggregation of alpha-synuclein/NACP in the neuronal and glial cells in diffuse Lewy body disease: a survey of six patients.
Piao YS; Wakabayashi K; Hayashi S; Yoshimoto M; Takahashi H
Clin Neuropathol; 2000; 19(4):163-9. PubMed ID: 10919347
[TBL] [Abstract][Full Text] [Related]
13. Alpha-synuclein in Lewy body disease and Alzheimer's disease.
Hashimoto M; Masliah E
Brain Pathol; 1999 Oct; 9(4):707-20. PubMed ID: 10517509
[TBL] [Abstract][Full Text] [Related]
14. The alpha-synucleinopathies: Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy.
Spillantini MG; Goedert M
Ann N Y Acad Sci; 2000; 920():16-27. PubMed ID: 11193145
[TBL] [Abstract][Full Text] [Related]
15. Alpha-synuclein inclusions in Alzheimer and Lewy body diseases.
Mukaetova-Ladinska EB; Hurt J; Jakes R; Xuereb J; Honer WG; Wischik CM
J Neuropathol Exp Neurol; 2000 May; 59(5):408-17. PubMed ID: 10888371
[TBL] [Abstract][Full Text] [Related]
16. Enhanced oligomerization of the alpha-synuclein mutant by the Cu,Zn-superoxide dismutase and hydrogen peroxide system.
Kang JH; Kim KS
Mol Cells; 2003 Feb; 15(1):87-93. PubMed ID: 12661766
[TBL] [Abstract][Full Text] [Related]
17. The A53T alpha-synuclein mutation increases iron-dependent aggregation and toxicity.
Ostrerova-Golts N; Petrucelli L; Hardy J; Lee JM; Farer M; Wolozin B
J Neurosci; 2000 Aug; 20(16):6048-54. PubMed ID: 10934254
[TBL] [Abstract][Full Text] [Related]
18. An in vitro model of Parkinson's disease: linking mitochondrial impairment to altered alpha-synuclein metabolism and oxidative damage.
Sherer TB; Betarbet R; Stout AK; Lund S; Baptista M; Panov AV; Cookson MR; Greenamyre JT
J Neurosci; 2002 Aug; 22(16):7006-15. PubMed ID: 12177198
[TBL] [Abstract][Full Text] [Related]
19. Patterns of protein nitration in dementia with Lewy bodies and striatonigral degeneration.
Gómez-Tortosa E; Gonzalo I; Newell K; García Yébenes J; Vonsattel P; Hyman BT
Acta Neuropathol; 2002 May; 103(5):495-500. PubMed ID: 11935266
[TBL] [Abstract][Full Text] [Related]
20. p25alpha Stimulates alpha-synuclein aggregation and is co-localized with aggregated alpha-synuclein in alpha-synucleinopathies.
Lindersson E; Lundvig D; Petersen C; Madsen P; Nyengaard JR; Højrup P; Moos T; Otzen D; Gai WP; Blumbergs PC; Jensen PH
J Biol Chem; 2005 Feb; 280(7):5703-15. PubMed ID: 15590652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]